ResearchDx news

Proteomics International

June 20, 2025

PromarkerD test for diabetic kidney disease

Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ), and ResearchDx DBA PacificDx proudly announce ProMarkerD, the groundbreaking predictive test for diabetic kidney disease. This innovative test empowers clinicians and patients by enabling early intervention to slow or prevent kidney function decline.

Press Release

@PromarkerD

Working on a diagnostic of your own?

From biomarker discovery to FDA clearance and CLIA testing, we can help.